STAT+: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Now that Eli Lilly is cutting prices on some of its insulin products, U.S. Sen. Bernie Sanders (I-Vt.) is seeking to build on that momentum. This week, he introduced a bill that would place a $20 cap on all insulin, a move designed to drastically lower costs for millions of Americans.
The legislation — dubbed the Insulin for All Act — would prohibit all insulin manufacturers from charging more than $20 per vial. In explaining the move, Sanders noted that Lilly did not reduce prices on all of its insulin products and that the other two big suppliers of the life-saving diabetes treatment — Sanofi and Novo Nordisk — have not committed to lower their prices.
Continue to STAT+ to read the full story…
